Noema Pharma AG
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.noemapharma.com
A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause
- Conditions
- MenopauseHot FlashesMenopause Syndrome
- Interventions
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Noema Pharma AG
- Target Recruit Count
- 24
- Registration Number
- NCT06385795
- Locations
- 🇺🇸
Noema PMM-201 Site #101, Atlanta, Georgia, United States
🇺🇸Noema PMM-201 Site #104, San Diego, California, United States
🇺🇸Noema PMM-201 Site #102, Jacksonville, Florida, United States
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Noema Pharma AG
- Target Recruit Count
- 180
- Registration Number
- NCT06315751
- Locations
- 🇪🇸
Noema TTS-201 Site #15, Burgos, Spain
🇪🇸Noema TTS-201 Site #27, Madrid, Spain
🇪🇸Noema TTS-201 Site #17, Oviedo, Spain
A Study to Validate a Pain Diary for Patient With Trigeminal Neuralgia
- Conditions
- Trigeminal Neuralgia
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Noema Pharma AG
- Target Recruit Count
- 30
- Registration Number
- NCT06019338
- Locations
- 🇬🇧
ULC Research, London, United Kingdom
🇺🇸Kainzen Centre, La Jolla, California, United States
A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Noema Pharma AG
- Target Recruit Count
- 75
- Registration Number
- NCT05583955
- Locations
- 🇦🇺
Noema Investigator site, Sydney, New South Wales, Australia
An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.
- First Posted Date
- 2022-02-01
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Noema Pharma AG
- Target Recruit Count
- 200
- Registration Number
- NCT05217628
- Locations
- 🇪🇸
Hospital Universitario Fundacion Jimenez Diaz (Site #: 1903), Madrid, Spain
🇪🇸Hospital Universitario La Paz - PPDS (Site #: 1907), Madrid, Spain
🇪🇸Hospital Universitario Virgen del Rocio - PPDS (Site #: 1904), Sevilla, Spain
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
- Conditions
- Tuberous Sclerosis Complex
- Interventions
- Drug: Placebo with crossover to Basimglurant
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Noema Pharma AG
- Target Recruit Count
- 61
- Registration Number
- NCT05059327
- Locations
- 🇮🇳
Rainbow Children's Hospital (Site # 803), Hyderabad, Andhra Pradesh, India
🇺🇸David Geffen School of Medicine at UCLA (Site #: 101), Los Angeles, California, United States
🇺🇸Kennedy Krieger Institute (Site #: 110), Baltimore, Maryland, United States